Latest stories

VS Pharmtech's VS-101 Turns Radiation Into a Sharper Weapon Against Cancer

VS Pharmtech's VS-101 Turns Radiation Into a Sharper Weapon Against Cancer

VS Pharmtech is developing VS-101, a repositioned radiosensitizer that weakens cancer cells' DNA repair and aims to boost existing treatments at roughly one-fifth the original dose. Early Korean trial data and FDA-cleared Phase 2 plans have put the Seoul startup on a global licensing path.

Hyperstar's AI Agent Ranks Influencers by Sales, Not Follower Counts

Hyperstar's AI Agent Ranks Influencers by Sales, Not Follower Counts

Hyperstar has launched an AI agent that selects influencers based on actual sales rather than follower counts, drawing on order data from eight sales channels. The Seoul-based startup says it has built a database of 10 million creators across 133 countries.